Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Pfizer Moving Antibacterial R&D from US to Shanghai

publication date: Mar 16, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Pfizer will close its R&D facility in Groton, Connecticut and move its antibacterials research operations to Shanghai. Although all major multinationals are doing research in China, it is highly unusual for a big pharma to move an entire lab there. More details....

Stock Symbol: (NYSE: PFE)     Share this with colleagues:  

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors